SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001564590-22-020653
Filing Date
2022-05-18
Accepted
2022-05-18 16:05:39
Documents
2
Effectiveness Date
2022-05-18

Document Format Files

Seq Description Document Type Size
1 POS EX stro-posex.htm POS EX 345148
2 EX-23.1 stro-ex231_6.htm EX-23.1 4148
  Complete submission text file 0001564590-22-020653.txt   350376
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-255014 | Film No.: 22939080
SIC: 2836 Biological Products, (No Diagnostic Substances)